Update shared on05 Sep 2025
With both the future P/E and discount rate for UTI Asset Management remaining nearly unchanged, analysts have left their consensus price target effectively steady at ₹1402.
What's in the News
- Upcoming board meeting to discuss the relinquishment of the current Managing Director & CEO position and consider the appointment of Mr. Vetri Subramaniam as Additional Director (Executive Category) and Managing Director & CEO, effective February 1, 2026.
- Announced annual dividend of INR 26.00 per share, payable in August, with ex-date and record date in July.
- Scheduled board meeting to consider and approve unaudited standalone and consolidated financial results for the quarter ending June 30, 2025.
Valuation Changes
Summary of Valuation Changes for UTI Asset Management
- The Consensus Analyst Price Target remained effectively unchanged, at ₹1402.
- The Future P/E for UTI Asset Management remained effectively unchanged, moving only marginally from 19.78x to 19.58x.
- The Discount Rate for UTI Asset Management remained effectively unchanged, moving only marginally from 14.68% to 14.67%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.